Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > What You Need to Know Ahead of DexCom’s Earnings Release
Economy

What You Need to Know Ahead of DexCom’s Earnings Release

Last updated: July 7, 2025 7:31 pm
Share
What You Need to Know Ahead of DexCom’s Earnings Release
SHARE

DexCom, Inc. (DXCM), a leading medical device company based in San Diego, specializes in continuous glucose monitoring (CGM) systems. With a market capitalization of $32.5 billion, DexCom’s innovative technology includes a small, implantable sensor that tracks glucose levels beneath the skin and transmits real-time data to an external receiver.

The company is set to announce its fiscal 2025 second-quarter earnings after the market closes on Wednesday, July 30. Analysts are anticipating a profit of $0.45 per share on a diluted basis, reflecting a 4.7% increase from the year-ago quarter’s $0.43 per share. While DexCom has exceeded consensus estimates in two of the last four quarters, it has fallen short on two other occasions.

Looking ahead, analysts project that DXCM will report earnings per share (EPS) of $2.03 for the full year, marking a 23.8% increase from $1.64 in fiscal 2024. Furthermore, the company’s EPS is expected to rise by 24.6% year over year to $2.53 in fiscal 2026.

Over the past 52 weeks, DexCom’s shares have declined by 25.2%, underperforming the S&P 500’s 13.4% gains and the Health Care Select Sector SPDR Fund’s 5.4% dip during the same period. On July 1, the company’s shares experienced a more than 4% drop following the U.S. government’s proposed changes to payment schedules and the introduction of a competitive bidding program for diabetes devices, impacting the broader glucose monitoring and insulin pump sector.

Despite these challenges, analysts maintain a very positive outlook on DXCM stock, with an overall “Strong Buy” rating. Out of 25 analysts covering the stock, 20 recommend a “Strong Buy,” one suggests a “Moderate Buy,” and four advise a “Hold.” The average analyst price target for DXCM is $99.68, indicating a potential upside of 20.2% from the current levels.

See also  10-year Treasury yield posts huge leap to 4.47% on Trump win, possible GOP Congress sweep

In conclusion, DexCom continues to innovate in the field of continuous glucose monitoring, despite recent market fluctuations. Investors and analysts remain optimistic about the company’s future prospects, highlighting its strong performance and potential for growth in the coming years.

This article was originally published on Barchart.com and has been rewritten for a WordPress platform, incorporating key points and information from the original source.

TAGGED:aheadDexcomsEarningsRelease
Share This Article
Twitter Email Copy Link Print
Previous Article Conozca sus derechos como inmigrante antes, durante y después de un desastre Conozca sus derechos como inmigrante antes, durante y después de un desastre
Next Article Roger Waters faces possible prosecution after supporting banned Palestine Action Roger Waters faces possible prosecution after supporting banned Palestine Action
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Amazon Restructures Healthcare Division and Renews Commitment To The Trillion Dollar Industry

Over the past decade, Amazon has embarked on a mission to revolutionize the healthcare industry,…

June 19, 2025

Groq and PlayAI just made voice AI sound way more human — here’s how

Groq and PlayAI have joined forces to introduce Dialog, an advanced text-to-speech model, on Groq's…

March 26, 2025

13 Fashion Hero Buys That Will Define the Fall-Winter Season

Title: Essential Fashion Must-Haves for Fall 2025: Your Ultimate Guide Introduction: Embrace the New Season…

September 26, 2025

Ronnie Radke Says Tommy Lee, Brittany Furlan Jab In New Music Video Is Good Fun

Ronnie Radke, the frontman of Falling In Reverse, has released a new music video that…

August 8, 2025

Our Best Dressed Men Channeled Elegance In Fall Fashion Pieces

Last week, the best-dressed men in the spotlight showcased a mix of bold and refined…

November 12, 2024

You Might Also Like

Is This The Best ETF to Invest In Ahead of Potential AI Bubble Burst?
Economy

Is This The Best ETF to Invest In Ahead of Potential AI Bubble Burst?

October 31, 2025
Alphabet hikes capex again after earnings beat on strong ad, cloud demand
Economy

Alphabet hikes capex again after earnings beat on strong ad, cloud demand

October 31, 2025
What is a merchant bank?
Economy

What is a merchant bank?

October 30, 2025
Fed Cuts Rates by a Quarter Point, as Expected
Economy

Fed Cuts Rates by a Quarter Point, as Expected

October 30, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?